Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

I think .20-.25 is realistic for next week.

There are millions of "short" shares that have to be bought with the shorts now competing against new buyers who are just finding out about the tremendous upside that AMBS offers.

$1.00 is probably three months away. It's just a matter of time before a "big pharma" company comes forth with a development partnership with a substantial upfront cash payment. A buyout at a much higher price is also possible longer term.

Amgen (AMGN) traded in the eight cent range when the company was first started. Now it is in the $90.00 range.

I can't understand why anyone would sell/short a $1.00 stock for five cent. :(


"One Med Forum"

http://finance.yahoo.com/news/amarantus-bioscience-present-onemedforum-2013-125200574.html